Quantitative and Qualitative Anamnestic Immune Responses to Pneumococcal Conjugate Vaccine in HIV‐Infected and HIV‐Uninfected Children 5 Years after Vaccination
Author(s) -
Shabir A. Madhi,
Keith P. Klugman,
Locadiah Kuwanda,
Clare Cutland,
Helena Käyhty,
Peter V. Adrian
Publication year - 2009
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/597388
Subject(s) - vaccination , medicine , pneumococcal conjugate vaccine , human immunodeficiency virus (hiv) , immunology , virology , immune system , pneumococcal infections , conjugate vaccine , immunization , streptococcus pneumoniae , biology , microbiology and biotechnology , antibiotics
Administration of pneumococcal conjugate vaccine (PCV) to HIV-infected children during infancy confers limited long-term protection in the absence of antiretroviral therapy. The objective of the present study was to determine the immune responses to PCV at 5 years of age in HIV-infected and HIV-uninfected children who had been primed with vaccine during infancy (i.e., previous vaccinees) and in those receiving their first dose of vaccine (i.e., control subjects).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom